Kelch domain of gigaxonin interacts with intermediate filament proteins affected in giant axonal neuropathy

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Johnson Kerner, Bethany L ^a,b   Diaz, Alejandro Garcia ^a,b   Ekins, Sean ^c   Wichterle, Hynek ^a,b  

^a Project ALS/Jenifer Estess Laboratory for Stem Cell Research   (United States)

^b Department of Medicine   (United States)

^c Collaborations in Chemistry ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ALPHA INTERNEXIN; CYTOPLASM PROTEIN; GIGAXONIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90AA1; HEAT SHOCK PROTEIN 90AB1; HEAT SHOCK PROTEIN A9; HEAT SHOCK PROTEIN D1; INTERMEDIATE FILAMENT PROTEIN; KERATIN 82; LAMIN B2; MYC BINDING PROTEIN 2; NEUROFILAMENT HEAVY CHAIN; NEUROFILAMENT LIGHT CHAIN; NEUROFILAMENT M PROTEIN; NEUROFILAMENT PROTEIN; PERIPHERIN; RIBOSOME PROTEIN; TUBULIN; UBIQUITIN; UBIQUITIN A; UBIQUITIN B; UBIQUITIN C; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIMENTIN; CYTOSKELETON PROTEIN; GAN PROTEIN, HUMAN; PROTEIN BINDING;

AFFINITY PURIFICATION; ARTICLE; BTB DOMAIN; COMPLEX FORMATION; CONTROLLED STUDY; GIANT AXONAL NEUROPATHY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KELCH DOMAIN; MASS SPECTROMETRY; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PURIFICATION; UBIQUITINATION; WESTERN BLOTTING; CHEMISTRY; HEK293 CELL LINE; METABOLISM; PROTEIN TERTIARY STRUCTURE; PROTEOMICS; STRUCTURE ACTIVITY RELATION;

CYTOSKELETAL PROTEINS; GIANT AXONAL NEUROPATHY; HEK293 CELLS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION MAPS; PROTEIN STRUCTURE, TERTIARY; PROTEOMICS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84948799406     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140157     Document Type: Article

References (30)

1. Asbury AK, Gale MK, Cox SC, Baringer JR, Berg BO. Giant axonal neuropathy-a unique case with segmental neurofilamentous masses. Acta neuropathologica. 1972;20(3):237-47. Epub 1972/01/01. PMID: 5044004.
2. Berg BO, Rosenberg SH, Asbury AK. Giant axonal neuropathy. Pediatrics. 1972;49(6):894-9. Epub 1972/06/01. PMID: 4339350.
3. Gordon N. Giant axonal neuropathy. Developmental medicine and child neurology. 2004;46(10):717-9. Epub 2004/10/12. PMID: 15473179.
4. Bomont P, Cavalier L, Blondeau F, Ben Hamida C, Belal S, Tazir M, et al. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nature genetics. 2000;26(3):370-4. Epub 2000/11/04. doi: 10.1038/81701 PMID: 11062483.
5. Johnson-Kerner BL, Roth L, Greene JP, Wichterle H, Sproule DM. Giant axonal neuropathy: An updated perspective on its pathology and pathogenesis. Muscle & nerve. 2014;50(4):467-76. Epub 2014/06/21. doi: 10.1002/mus.24321 PMID: 24947478.
6. Prag S, Adams JC. Molecular phylogeny of the kelch-repeat superfamily reveals an expansion of BTB/kelch proteins in animals. BMC bioinformatics. 2003;4:42. Epub 2003/09/19. doi: 10.1186/1471-2105-4-42 PMID: 13678422; PubMed Central PMCID: PMCPMC222960.
7. Zhang DD, Lo SC, Sun Z, Habib GM, Lieberman MW, Hannink M. Ubiquitination of Keap1, a BTBKelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway. The Journal of biological chemistry. 2005;280(34):30091-9. Epub 2005/06/29. doi: 10.1074/jbc. M501279200 PMID: 15983046.
8. Bennett EJ, Rush J, Gygi SP, Harper JW. Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics. Cell. 143(6):951-65. doi: 10.1016/j.cell.2010.11.017 PMID: 21145461
9. Lariviere RC, Julien JP. Functions of intermediate filaments in neuronal development and disease. Journal of neurobiology. 2004;58(1):131-48. Epub 2003/11/05. doi: 10.1002/neu.10270 PMID: 14598376.
10. Liem RK, Messing A. Dysfunctions of neuronal and glial intermediate filaments in disease. The Journal of clinical investigation. 2009;119(7):1814-24. Epub 2009/07/10. doi: 10.1172/jci38003 PMID: 19587456; PubMed Central PMCID: PMCPMC2701870.
11. Bomont P, Koenig M. Intermediate filament aggregation in fibroblasts of giant axonal neuropathy patients is aggravated in non dividing cells and by microtubule destabilization. Human molecular genetics. 2003;12(8):813-22. Epub 2003/04/02. PMID: 12668605.
12. Cleveland DW, Yamanaka K, Bomont P. Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway. Human molecular genetics. 2009;18(8):1384-94. Epub 2009/01/27. doi: 10.1093/hmg/ddp044 PMID: 19168853; PubMed Central PMCID: PMCPMC2664145.
13. Peiffer J, Schlote W, Bischoff A, Boltshauser E, Muller G. Generalized giant axonal neuropathy: a filamentforming disease of neuronal, endothelial, glial, and schwann cells in a patient without kinky hair. Acta neuropathologica. 1977;40(3):213-8. Epub 1977/11/28. PMID: 602684.
14. Ding J, Liu JJ, Kowal AS, Nardine T, Bhattacharya P, Lee A, et al. Microtubule-associated protein 1B: a neuronal binding partner for gigaxonin. The Journal of cell biology. 2002;158(3):427-33. Epub 2002/07/31. doi: 10.1083/jcb.200202055 PMID: 12147674; PubMed Central PMCID: PMCPMC2173828.
15. Mahammad S, Murthy SN, Didonna A, Grin B, Israeli E, Perrot R, et al. Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation. The Journal of clinical investigation. 2013;123(5):1964-75. Epub 2013/04/16. doi: 10.1172/jci66387 PMID: 23585478; PubMed Central PMCID: PMCPMC3635735.
16. Cullen VC, Brownlees J, Banner S, Anderton BH, Leigh PN, Shaw CE, et al. Gigaxonin is associated with the Golgi and dimerises via its BTB domain. Neuroreport. 2004;15(5):873-6. Epub 2004/04/10. PMID: 15073534.
17. Dennis G Jr., Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome biology. 2003;4(5):P3. Epub 2003/05/08. PMID: 12734009; PubMed Central PMCID: PMCPMC3720094.
18. Mussche S, De Paepe B, Smet J, Devreese K, Lissens W, Rasic VM, et al. Proteomic analysis in giant axonal neuropathy: new insights into disease mechanisms. Muscle & nerve. 2012;46(2):246-56. Epub 2012/07/19. doi: 10.1002/mus.23306 PMID: 22806374.
19. McCallum CD, Do H, Johnson AE, Frydman J. The interaction of the chaperonin tailless complex polypeptide 1 (TCP1) ring complex (TRiC) with ribosome-bound nascent chains examined using photocrosslinking. The Journal of cell biology. 2000;149(3):591-602. Epub 2000/05/03. PMID: 10791973; PubMed Central PMCID: PMCPMC2174856.
20. Shaw G, Morse S, Ararat M, Graham FL. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2002;16(8):869-71. Epub 2002/04/23. doi: 10.1096/fj. 01-0995fje PMID: 11967234.
21. Pena SD. Giant axonal neuropathy: an inborn error of organization of intermediate filaments. Muscle & nerve. 1982;5(2):166-72. Epub 1982/02/01. doi: 10.1002/mus.880050215 PMID: 6280044.
22. Escurat M, Djabali K, Gumpel M, Gros F, Portier MM. Differential expression of two neuronal intermediatefilament proteins, peripherin and the low-molecular-mass neurofilament protein (NF-L), during the development of the rat. The Journal of neuroscience: the official journal of the Society for Neuroscience. 1990;10(3):764-84. Epub 1990/03/01. PMID: 2108230.
23. Huang L, Ho P, Chen CH. Activation and inhibition of the proteasome by betulinic acid and its derivatives. FEBS letters. 2007;581(25):4955-9. Epub 2007/10/02. doi: 10.1016/j.febslet.2007.09.031 PMID: 17904555; PubMed Central PMCID: PMCPMC2083647.
24. Theodoraki MA, Caplan AJ. Quality control and fate determination of Hsp90 client proteins. Biochimica et biophysica acta. 2012;1823(3):683-8. Epub 2011/08/30. doi: 10.1016/j.bbamcr.2011.08.006 PMID: 21871502; PubMed Central PMCID: PMCPMC3242914.
25. Allen E, Ding J, Wang W, Pramanik S, Chou J, Yau V, et al. Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival. Nature. 2005;438(7065):224-8. Epub 2005/10/18. doi: 10.1038/nature04256 PMID: 16227972.
26. Wang W, Ding J, Allen E, Zhu P, Zhang L, Vogel H, et al. Gigaxonin interacts with tubulin folding cofactor B and controls its degradation through the ubiquitin-proteasome pathway. Current biology: CB. 2005;15(22):2050-5. Epub 2005/11/24. doi: 10.1016/j.cub.2005.10.052 PMID: 16303566.
27. Ding J, Allen E, Wang W, Valle A, Wu C, Nardine T, et al. Gene targeting of GAN in mouse causes a toxic accumulation of microtubule-associated protein 8 and impaired retrograde axonal transport. Human molecular genetics. 2006;15(9):1451-63. Epub 2006/03/28. doi: 10.1093/hmg/ddl069 PMID: 16565160.
28. Bennett EJ, Rush J, Gygi SP, Harper JW. Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics. Cell. 2010;143(6):951-65. Epub 2010/12/15. doi: 10.1016/j.cell. 2010.11.017 PMID: 21145461; PubMed Central PMCID: PMCPMC3008586.
29. D'Angiolella V, Donato V, Vijayakumar S, Saraf A, Florens L, Washburn MP, et al. SCF (Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation. Nature. 2010;466(7302):138-42. Epub 2010/07/03. doi: 10.1038/nature09140 PMID: 20596027; PubMed Central PMCID: PMCPMC2946399.
30. Mellacheruvu D, Wright Z, Couzens AL, Lambert JP, St-Denis NA, Li T, et al. The CRAPome: a contaminant repository for affinity purification-mass spectrometry data. Nature methods. 2013;10(8):730-6. Epub 2013/08/08. doi: 10.1038/nmeth.2557 PMID: 23921808; PubMed Central PMCID: PMCPMC3773500.